364 results
DEFA14A
LCTX
Lineage Cell Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
4:40pm
Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
P.O. BOX 8016, CARY, NC 27512
8-K
EX-1.1
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
, biologics or biohazardous substances or materials) necessary for the ownership or lease of their respective properties or to conduct its businesses … delisted from the Exchange.
(k)Other Materials. On each date on which the Company is required to deliver a certificate pursuant to Section 7(l
8-K
uieaui vzek
15 Feb 24
Other Events
5:27pm
8-K
EX-99.1
341svq
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
8-K
EX-10.1
68i9367bx
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
8-K
EX-99.1
altye1gknet1 xi8noz
9 Nov 23
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm
8-K
g67f52psschh kraj
7 Sep 23
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
j9oajcoc5zjh
10 Aug 23
LINEAGE CELL THERAPEUTICS REPORTs SECOND QUARTER 2023 FINANCIAL
4:10pm
DEFA14A
66234vnj5sus9 2xwsrk
27 Jul 23
Additional proxy soliciting materials
4:10pm
8-K
ey9hkyu
21 Jun 23
Other Events
5:00pm
8-K
EX-99.1
rjlrtqcyj ziv
11 May 23
LINEAGE CELL THERAPEUTICS REPORTs FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:10pm
8-K
EX-99.1
ll1dh
10 Nov 22
LINEAGE CELL THERAPEUTICS REPORTs THIRD QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:11pm